Chat with us
Research Assistance
Online
  • Please enter your first name.

Europe Psoriasis Drugs Market Size & Outlook, 2026-2033

The psoriasis drugs market in Europe is expected to reach a projected revenue of US$ 14,158.8 million by 2033. A compound annual growth rate of 10.7% is expected of Europe psoriasis drugs market from 2026 to 2033.

  • Pharmaceuticals
    • Skin Care Treatment
      • Psoriasis Drugs Market Outlook
Revenue, 2025 (US$M)
$6,323.1
Estimate, 2026 (US$M)
$6,940.0
Forecast, 2033 (US$M)
$14,158.8
CAGR, 2026 - 2033
10.7%
Prism AI by Grand View ResearchFree to try

Ask a question about the psoriasis drugs market

Every figure cited from GVR research

Europe psoriasis drugs market highlights

  • The Europe psoriasis drugs market generated a revenue of USD 6,323.1 million in 2025.
  • The market is expected to grow at a CAGR of 10.7% from 2026 to 2033.
  • In terms of segment, tumor necrosis factor inhibitors was the largest revenue generating class in 2025.
  • Interleukin Inhibitors is the most lucrative class segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.


Europe data book summary

Market revenue in 2025USD 6,323.1 million
Market revenue in 2033USD 14,158.8 million
Growth rate10.7% (CAGR from 2026 to 2033)
Largest segmentTumor necrosis factor inhibitors
Fastest growing segmentInterleukin Inhibitors
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationTumor Necrosis Factor Inhibitors, Interleukin Inhibitors, Vitamin-D Analogues, Corticosteriods
Key market players worldwideAbbVie Inc, Amgen Inc, Johnson & Johnson Services, Inc., Novartis AG, Eli Lilly and Company, AstraZeneca PLC, Celgene Corporation, UCB SA, Merck KGaA, Boehringer Ingelheim International GmbH


Other key industry trends

  • In terms of revenue, Europe region accounted for 27.2% of the global psoriasis drugs market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 15,906.9 million by 2033.

No credit card required*

Publish Date: Jul 23, 2026

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Psoriasis Drugs Market Companies

NameProfile# EmployeesHQWebsite
Amgen IncView profile 26,700One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799www.amgen.com
Merck KGaAView profile 62,345Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293www.emdgroup.com
AbbVie IncView profile 50,0001 North Waukegan Road, North Chicago, IL, United States, 60064-6400www.abbvieinvestor.com
UCB SAView profile 9,083Allee de la Recherche, 60, Brussels, Belgium, B-1070www.ucb.com
AstraZeneca PLCView profile 89,9001 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AAwww.astrazeneca.com
Novartis AGView profile ---
Johnson & Johnson Services, Inc.View profile ---
Eli Lilly and CompanyView profile ---
Celgene CorporationView profile ---
Boehringer Ingelheim International GmbHView profile ---

Europe Psoriasis Drugs Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Psoriasis Drugs Market Outlook will help companies and investors design strategic landscapes.


Tumor Necrosis Factor Inhibitors was the largest segment with a revenue share of 44.63% in 2025.

Horizon Databook has segmented the Europe psoriasis drugs market based on tumor necrosis factor inhibitors, interleukin inhibitors, vitamin-d analogues, corticosteriods covering the revenue growth of each sub-segment from 2021 to 2033.


  • Europe Psoriasis Drugs Market Class Outlook (Revenue, USD Million , 2021-2033)
    • Tumor Necrosis Factor Inhibitors
    • InterleU.S.in Inhibitors
    • Vitamin-D Analogues
    • Corticosteriods
    • Others
  • Europe Psoriasis Drugs Market Treatment Outlook (Revenue, USD Million , 2021-2033)
    • Topicals
    • Systemic
    • Biologics
  • Europe Psoriasis Drugs Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
    • Oral
    • Parenteral
    • Topical
  • Europe Psoriasis Drugs Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Others

Reasons to subscribe to Psoriasis Drugs Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Psoriasis Drugs Market Outlook databook

  • Our clientele includes a mix of Psoriasis Drugs Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Psoriasis Drugs Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Psoriasis Drugs Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Europe Psoriasis Drugs Market, 2021-2033 (US$M)

No Access Stack Chart

Europe Class - Psoriasis Drugs Market Statistics, 2025 - 2033 (US$M)

No Access Pie Chart

Europe psoriasis drugs market statistics, by country, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more